Epidemiology of spina bifida in Tottori Prefecture, Japan, 1976-1995

Pediatric Neurology

Volumn 19, Issue 3, 1998, Pages 199-203

  Ehara, Hiroaki ^a   Ohno, Kousaku ^b   Ohtani, Kyoichi ^c   Koeda, Tatsuya ^a   Takeshita, Kenzo ^a  

^a Div of Child Neurol Inst of N   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c Tottori Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; INCIDENCE; JAPAN; MALE; PRIORITY JOURNAL; SPINA BIFIDA;

DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; REGISTRIES; SEASONS; SEX DISTRIBUTION; SPINAL DYSRAPHISM;

EID: 0032169148     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00048-4     Document Type: Article

References (29)

1. Smithells R.W., Sheppard S., Schorah C.J., et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. 1:1980;339-340.
2. Smithells R.W., Nevin N.C., Seller M.J., et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1:1983;1027-1031.
3. Prevention of neural tube defects Results of the Medical Research Council Vitamin Study . Lancet. 338:1991;131-137.
4. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 41:(RR#14):1992;1-7.
5. van der Put N.M., Steegers-Theunissen R.P.M., Frosst P., et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
6. Hol F.A., Geurds M.P.A., Chatkupt S., et al. PAX genes and human neural tube defects An amino acid substitution in PAX1 in a patient with spina bifida . J Med Genet. 33:1996;655-660.
7. Hol F.A., Hamel B.C.J., Geurds M.P.A., et al. A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome. J Med Genet. 32:1995;52-56.
8. Copp A.J., Brook F.A., Roberts H.J. A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. Development. 104:1988;285-295.
9. Zhao Q., Behringer R.R., de Crombrugghe B. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nat Genet. 3:1996;275-283.
10. Kromberg J.G.R., Jenkins T. Common birth defects in South African blacks. S Afr Med J. 62:1982;599-602.
11. MacLean M.H., MacLeod A. Seasonal variation in the frequency of anencephalus and spina bifida births in the United Kingdom. J Epidemiol Community Health. 38:1984;99-102.
12. Ericson A., Källén B., Westerholm P. Clusters of malformations in Sweden A study with central registers . Environ Res. 30:1983;466-479.
13. Mitani S. Malformations of newborns. Sanka to Fujinka. 11:1943;345-356. (in Japanese).
14. Neel J.V. A study of major congenital defects in Japanese infants. Am J Hum Genet. 10:1958;398-445.
15. Imaizumi Y. Statistical analysis on anencephaly, spina bifida and congenital hydrocephaly in Japan. Jpn J Hum Genet. 19:1974;115-135.
16. Elwood J.M., Elwood J.H. Distribution by sex. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;130-138 Oxford University Press, Oxford.
17. Davis C.F., Young D.G. The changing incidence of neural tube defects in Scotland. J Pediatr Surg. 26:1991;516-518.
18. Laurence K.M. The apparently declining prevalence of neural tube defects in two counties in South Wales over three decades illustrating the need for continuing action and vigilance. Z Kinderchir. 40:(suppl 1):1985;58-60.
19. Nevin N.C. Neural tube defects. Lancet. 1981;1290-1291.
20. Källén B., Löfkvist E. Time trends of spina bifida in Sweden 1947-81. J Epidemiol Community Health. 38:1984;103-107.
21. Naggan L. The recent decline in prevalence of anencephaly and spina bifida. Am J Epidemiol. 80:1969;154-160.
22. Windham G.C., Edmonds L.D. Current trends in the incidence of neural tube defects. Pediatrics. 70:1982;333-337.
23. Stein S.C., Feldman J.G., Friedlander M., Klein R.J. Is myelomeningocele a disappearing disease? Pediatrics. 69:1982;511-514.
24. Elwood J.M., Elwood J.H. Secular trends. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;107-119 Oxford University Press, Oxford.
25. Chan A., Robertson E.F., Haan E.A., Keane R.J., Ranieri E., Carney A. Prevalence of neural tube defects in South Australia, 1966-91 Effectiveness and impact of prenatal diagnosis . BMJ. 307:1993;703-706.
26. Elwood J.M., Elwood J.H. Geographical variation. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;87-100 Oxford University Press, Oxford.
27. Elwood J.M., Elwood J.H. Clustering in time and space. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;175-178 Oxford University Press, Oxford.
28. Elwood J.M., Elwood J.H. Seasonal variation. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;120-129 Oxford University Press, Oxford.
29. Elwood J.M., Elwood J.H. Drinking-water composition. Elwood J.M., Elwood J.H. Epidemiology of anencephalus and spina bifida. 1980;167-174 Oxford University Press, Oxford.